- Home
- LASR vs GOSS Comparison
LASR vs GOSS Comparison
Compare LASR & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LASR
- GOSS
- Stock Information
- Founded
- LASR 2000
- GOSS 2015
- Country
- LASR United States
- GOSS United States
- Employees
- LASR N/A
- GOSS N/A
- Industry
- LASR Semiconductors
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- LASR Technology
- GOSS Health Care
- Exchange
- LASR Nasdaq
- GOSS Nasdaq
- Market Cap
- LASR 903.8M
- GOSS 726.8M
- IPO Year
- LASR 2018
- GOSS 2019
- Fundamental
- Price
- LASR $33.23
- GOSS $3.31
- Analyst Decision
- LASR Strong Buy
- GOSS Strong Buy
- Analyst Count
- LASR 6
- GOSS 6
- Target Price
- LASR $32.67
- GOSS $8.60
- AVG Volume (30 Days)
- LASR 861.7K
- GOSS 2.7M
- Earning Date
- LASR 11-06-2025
- GOSS 11-05-2025
- Dividend Yield
- LASR N/A
- GOSS N/A
- EPS Growth
- LASR N/A
- GOSS N/A
- EPS
- LASR N/A
- GOSS N/A
- Revenue
- LASR $227,526,000.00
- GOSS $44,051,000.00
- Revenue This Year
- LASR $23.44
- GOSS N/A
- Revenue Next Year
- LASR $8.73
- GOSS $16.11
- P/E Ratio
- LASR N/A
- GOSS N/A
- Revenue Growth
- LASR 12.05
- GOSS N/A
- 52 Week Low
- LASR $6.20
- GOSS $0.67
- 52 Week High
- LASR $38.62
- GOSS $3.60
- Technical
- Relative Strength Index (RSI)
- LASR 56.01
- GOSS 69.77
- Support Level
- LASR $28.09
- GOSS $2.93
- Resistance Level
- LASR $31.31
- GOSS $3.28
- Average True Range (ATR)
- LASR 2.55
- GOSS 0.21
- MACD
- LASR -0.03
- GOSS 0.08
- Stochastic Oscillator
- LASR 49.86
- GOSS 95.13
About LASR nLIGHT Inc.
nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.